SciSparc Ltd.(SPRC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SPRC SciSparc Ltd.

Pre-Mkt 02-04 05:11:32 EST

0.7545

-0.0155

-2.01%

High0.8150	Low0.7250	Vol250.92K
Open0.7819	D1 Closing0.7700	Amplitude11.69%
Mkt Cap3.28M	Tradable Cap2.85M	Total Shares4.35M
T/O193.11K	T/O Rate6.65%	Tradable Shares3.77M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SPRC","market":"US","secType":"STK","nameCN":"SciSparc Ltd.","latestPrice":0.7545,"timestamp":1770152400000,"preClose":0.77,"halted":0,"volume":250920,"delay":0,"changeRate":-0.02012987012987022,"floatShares":3774900,"shares":4350501,"eps":-22.654922,"marketStatus":"Pre-Mkt","change":-0.0155,"latestTime":"02-04 05:11:32 EST","open":0.7819,"high":0.815,"low":0.725,"amount":193105.078672,"amplitude":0.116883,"askPrice":0.77,"askSize":29,"bidPrice":0.727,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-22.654922,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770215400000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":0.7545,"postHourTrading":{"tag":"盘后","latestPrice":0.7487,"preClose":0.7545,"latestTime":"19:49 EST","volume":18737,"amount":13731.1059,"timestamp":1770166187271,"change":-0.0058,"changeRate":-0.007687,"amplitude":0.0444},"volumeRatio":0.8528683185383814},"requestUrl":"/m/hq/s/SPRC","defaultTab":"news","newsList":[{"id":"2608383213","title":"SciSparc files $50M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2608383213","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608383213?lang=en_us&edition=fundamental","pubTime":"2026-02-04 05:40","pubTimestamp":1770154829,"startTime":"0","endTime":"0","summary":"16:38 EST SciSparc (SPRC)files $50M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking fi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scisparc-files-50m-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scisparc-files-50m-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SPRC","BK4139"],"gpt_icon":0},{"id":"2608996383","title":"Scisparc Ltd - to Offer up to $50 Mln in Securities - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2608996383","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608996383?lang=en_us&edition=fundamental","pubTime":"2026-02-04 05:37","pubTimestamp":1770154654,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nFWN3YZ14H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","SPRC"],"gpt_icon":0},{"id":"2608386475","title":"SciSparc says Neurothera Labs granted U.S. patent for cannabinoid tech","url":"https://stock-news.laohu8.com/highlight/detail?id=2608386475","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608386475?lang=en_us&edition=fundamental","pubTime":"2026-02-02 21:36","pubTimestamp":1770039371,"startTime":"0","endTime":"0","summary":"SciSparc (SPRC)announced that NeuroThera Labs, in which SciSparc holds a controlling interest of approximately 75%, announced that the United State...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scisparc-says-neurothera-labs-granted-u-s-patent-for-cannabinoid-tech-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scisparc-says-neurothera-labs-granted-u-s-patent-for-cannabinoid-tech-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4135","LU0061475181.USD","LU1894683348.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU1894683264.USD","LU1883839398.USD","IE0034235188.USD","BK4139","IE00B3QW5Z07.USD","STT","BK4007","BK4585","BK4588","SPRC"],"gpt_icon":0},{"id":"2608864800","title":"Scisparc: Neurothera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance Such as Mrsa","url":"https://stock-news.laohu8.com/highlight/detail?id=2608864800","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608864800?lang=en_us&edition=fundamental","pubTime":"2026-02-02 21:25","pubTimestamp":1770038717,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nFWN3YY0I6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SPRC","BK4007"],"gpt_icon":0},{"id":"2608864853","title":"SciSparc Ltd.: NeuroThera Labs Granted U.S. Patent for Cannabinoid-Enhanced Antimicrobial Technology to Combat Antibiotic Resistance","url":"https://stock-news.laohu8.com/highlight/detail?id=2608864853","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608864853?lang=en_us&edition=fundamental","pubTime":"2026-02-02 21:24","pubTimestamp":1770038650,"startTime":"0","endTime":"0","summary":"SciSparc Ltd.: NeuroThera Labs Granted U.S. Patent for Cannabinoid-Enhanced Antimicrobial Technology to Combat Antibiotic Resistance. SciSparc Ltd. announced that NeuroThera Labs has been granted a U.S. patent for its proprietary combination of antimicrobials and cannabinoids. The patent covers innovative compositions and methods aimed at enhancing the efficacy of existing antibiotics against resistant bacterial strains, such as MRSA. This development further strengthens the intellectual property protection of NeuroThera’s antimicrobial-potentiating platform, which targets the escalating challenge of antimicrobial resistance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scisparc Ltd. published the original content used to generate th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nNDLb51P9K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","IE00BGHQF748.EUR","SG9999014039.USD","LU2210150020.SGD","BK4139","SG9999014021.USD","BK4007","LU2210149790.SGD","IE00B3QW5Z07.USD","SG9999014005.SGD","BK4585","NDAQ","LU0314104364.USD","BK4112","SPRC","SG9999014013.SGD","BK4588","LU2095319765.USD","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2606243561","title":"SciSparc completes acquisition of IP portfolio of patents, trademarks","url":"https://stock-news.laohu8.com/highlight/detail?id=2606243561","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606243561?lang=en_us&edition=fundamental","pubTime":"2026-01-26 21:20","pubTimestamp":1769433659,"startTime":"0","endTime":"0","summary":"SciSparc (SPRC)announced the closing of the acquisition of an IP portfolio of patents, trademarks and intellectual property rights for innovative e...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scisparc-completes-acquisition-of-ip-portfolio-of-patents-trademarks-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scisparc-completes-acquisition-of-ip-portfolio-of-patents-trademarks-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1481600234.SGD","BK4585","LU1481599808.USD","SPRC","BK4588","BK4139","LU2463526074.USD","LU1169589451.USD","LU1169590202.USD","BK4007","IP","IE00B3T34201.USD","BK4136","LU1487256676.USD"],"gpt_icon":0},{"id":"2606224879","title":"SciSparc Acquires MUSE System IP Portfolio from Xylo Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2606224879","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606224879?lang=en_us&edition=fundamental","pubTime":"2026-01-26 21:13","pubTimestamp":1769433190,"startTime":"0","endTime":"0","summary":"SciSparc Ltd. has completed the acquisition of an intellectual property portfolio from Xylo Technologies Ltd., including patents, trademarks, and know-how related to the MUSE system—an innovative endoscopic device for minimally invasive treatment of GERD. SciSparc plans to commercialize these technologies globally, building on Xylo’s previous licensing success in Greater China and targeting new partnerships in North America, Europe, and Latin America.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scisparc Ltd. published the original content used to generate this news brief via GlobeNewswire  on January 26, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDL9m2Kwh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","BK4588","NDAQ","LU2095319765.USD","BK4007","SPRC","LU2210149790.SGD","IE00BKPKM429.USD","LU2210150020.SGD","SG9999014005.SGD","BK4112","IE00B3QW5Z07.USD","LU0314104364.USD","SG9999014021.USD","SG9999014013.SGD","SG9999014039.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2606248752","title":"Scisparc Successfully Completes Acquisition of Ip Portfolio, Advances Toward Immediate Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=2606248752","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606248752?lang=en_us&edition=fundamental","pubTime":"2026-01-26 21:13","pubTimestamp":1769433180,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nTUA2WWZ44:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRC","BK4007","BK4139"],"gpt_icon":0},{"id":"2603321516","title":"SciSparc Moves Into Endoscopy With Strategic Patent Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2603321516","media":"Benzinga","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603321516?lang=en_us&edition=fundamental","pubTime":"2026-01-14 02:39","pubTimestamp":1768329540,"startTime":"0","endTime":"0","summary":"SciSparc shares fall after the company agrees to acquire endoscopy-related patents as it pushes into medical devices.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/13/health-care.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/13/health-care.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/markets/equities/26/01/49886690/scisparc-moves-into-endoscopy-with-strategic-patent-deal","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/01/49886690/scisparc-moves-into-endoscopy-with-strategic-patent-deal","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["SPRC","BK4139","BK4007"],"gpt_icon":0},{"id":"2603689345","title":"BUZZ-SciSparc jumps as it buys acid reflux device patents, eyes global push","url":"https://stock-news.laohu8.com/highlight/detail?id=2603689345","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603689345?lang=en_us&edition=fundamental","pubTime":"2026-01-13 20:20","pubTimestamp":1768306835,"startTime":"0","endTime":"0","summary":"BUZZ-SciSparc jumps as it buys acid reflux device patents, eyes global push** Shares of Israel-based drug developer SciSparc SPRC.O rise 56.2% to $2.29 premarket   ** Co says it has signed a deal to buy patents and intellectual property for endoscopic medical devices, including the MUSE system, from Xylo Technologies** MUSE is a single-use device for minimally invasive treatment of acid reflux disease - co** Co says deal expected to close March 8; Xylo to get 19.99% of SciSparc's share capital or pre-funded warrants** SPRC plans global expansion via distributors in North America, Europe, Latin America - SPRC** As of last close, stock down ~82% over the past year  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nL4N3YE10Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRC","BK4007","BK4139"],"gpt_icon":0},{"id":"2603744685","title":"SciSparc to Acquire Xylo’s MUSE Endoscopic Device Portfolio for 19.99% Equity Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2603744685","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603744685?lang=en_us&edition=fundamental","pubTime":"2026-01-13 19:55","pubTimestamp":1768305310,"startTime":"0","endTime":"0","summary":"SciSparc Ltd. has signed a definitive agreement to acquire a portfolio of patents, trademarks, and intellectual property associated primarily with the MUSE endoscopic system from Xylo Technologies Ltd. The MUSE system is a single-use, innovative device designed for transoral fundoplication, a minimally invasive procedure to treat gastroesophageal reflux disease . As consideration for the acquired assets, SciSparc will issue to Xylo ordinary shares representing 19.99% of its issued and outstanding share capital as of the closing date, set for March 8, 2026, or may elect to issue pre-funded warrants in lieu of shares. SciSparc plans to begin commercializing the technologies immediately after closing, aiming to replicate Xylo's successful licensing model in Greater China by pursuing exclusive partnerships with regional distributors in North America, Europe, and Latin America. The transaction is subject to customary closing conditions.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDLb237cL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","BK4139","LU0314104364.USD","SG9999014039.USD","LU2095319765.USD","IE00B64PRP62.GBP","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","SPRC","LU2210150020.SGD","IE00B3QW5Z07.USD","SG9999014021.USD","BK4007","NDAQ","BK4112","BK4585","SG9999014005.SGD","BK4588"],"gpt_icon":0},{"id":"2603857756","title":"Scisparc Ltd - to Buy Muse System Patents From Xylo","url":"https://stock-news.laohu8.com/highlight/detail?id=2603857756","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603857756?lang=en_us&edition=fundamental","pubTime":"2026-01-13 19:55","pubTimestamp":1768305300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nTUA5G4DMK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SPRC","BK4007"],"gpt_icon":0},{"id":"2603685778","title":"Scisparc Ltd - to Issue 19.99% Shares to Xylo Upon Closing","url":"https://stock-news.laohu8.com/highlight/detail?id=2603685778","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603685778?lang=en_us&edition=fundamental","pubTime":"2026-01-13 19:55","pubTimestamp":1768305300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nTUA5G4DMK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRC","BK4139","BK4007"],"gpt_icon":0},{"id":"2603685739","title":"Scisparc Signs Definitive Agreement to Acquire a Treasury of Patents for the Endoscope Market- Entering Multi-Billion Dollar Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2603685739","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603685739?lang=en_us&edition=fundamental","pubTime":"2026-01-13 19:55","pubTimestamp":1768305300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nTUA5G4DMK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SPRC","BK4139"],"gpt_icon":0},{"id":"2603526652","title":"Scisparc Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2603526652","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603526652?lang=en_us&edition=fundamental","pubTime":"2026-01-13 05:10","pubTimestamp":1768252239,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nFWN3YD1N6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SPRC","BK4139"],"gpt_icon":0},{"id":"2603824526","title":"SciSparc Receives Nasdaq Non-Compliance Notice Over Minimum Equity Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2603824526","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603824526?lang=en_us&edition=fundamental","pubTime":"2026-01-13 05:02","pubTimestamp":1768251733,"startTime":"0","endTime":"0","summary":"Scisparc Ltd. has received a notification from the Nasdaq Stock Market indicating non-compliance with the minimum stockholders' equity requirement for continued listing on the Nasdaq Capital Market. The company reported a stockholders' equity of approximately negative $81,000 as of June 30, 2025, falling below the required $2.5 million. Scisparc has until February 26, 2026, to submit a plan to regain compliance, and if accepted, could receive up to 180 days to meet the requirement. The notification does not immediately affect the company's Nasdaq listing, and Scisparc expects to demonstrate compliance following recent financial actions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scisparc Ltd. published the original content used to ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDLbmdyTS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU0314104364.USD","LU2210150020.SGD","BK4007","BK4139","BK4112","LU2210149790.SGD","SG9999014021.USD","SPRC","NDAQ","BK4588","IE00B3QW5Z07.USD","SG9999014013.SGD","SG9999014039.USD","BK4585","LU2095319765.USD","IE00B64PRP62.GBP","IE00BKPKM429.USD","SG9999014005.SGD"],"gpt_icon":0},{"id":"2595179790","title":"SciSparc’s Neurothera Labs Granted Israeli Patent for Opioid-PEA Combination to Enhance Pain Relief and Reduce Side Effects","url":"https://stock-news.laohu8.com/highlight/detail?id=2595179790","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595179790?lang=en_us&edition=fundamental","pubTime":"2025-12-30 21:17","pubTimestamp":1767100629,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scisparc Ltd. published the original content used to generate this news brief via GlobeNewswire  on December 30, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nNDL24HF5K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","BK4585","LU2210150020.SGD","BK4139","IE00BKPKM429.USD","IE00BGHQF748.EUR","LU0314104364.USD","IE00B64PRP62.GBP","BK4112","SG9999014039.USD","SG9999014021.USD","NDAQ","SG9999014013.SGD","LU2095319765.USD","BK4588","IE00B3QW5Z07.USD","BK4007","SG9999014005.SGD","SPRC"],"gpt_icon":0},{"id":"2588805970","title":"Scisparc Ltd - Neurothera to Buy 55% Equity Interest in Target Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2588805970","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588805970?lang=en_us&edition=fundamental","pubTime":"2025-12-02 22:29","pubTimestamp":1764685740,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nTUA9MXTVV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRC","BK4007","BK4139"],"gpt_icon":0},{"id":"2588059248","title":"Scisparc: Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum Algorithm Bio Data Analysis Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2588059248","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588059248?lang=en_us&edition=fundamental","pubTime":"2025-12-02 22:29","pubTimestamp":1764685740,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nTUA3GBC7C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRC","BK4007","BK4139"],"gpt_icon":0},{"id":"2588053724","title":"Neurothera Labs to Acquire 55% Stake in Quantum Bio Data Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2588053724","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588053724?lang=en_us&edition=fundamental","pubTime":"2025-12-02 21:05","pubTimestamp":1764680725,"startTime":"0","endTime":"0","summary":"Neurothera Labs Inc., a clinical-stage biotech company and majority-owned subsidiary of SciSparc Ltd., has entered into a non-binding term sheet to acquire a 55% equity interest in a pioneering quantum computing bio data analysis company. The transaction, if completed, will see Neurothera issue common shares equal to 40% of its post-transaction, non-diluted share capital to certain selling shareholders of the target company. The quantum-enabled clinical analytics firm specializes in leveraging quantum computing to enhance the storage, manipulation, and analysis of bio data, with the goal of accelerating medical research and redefining clinical trials through advanced machine learning and data science. Completion of the acquisition remains subject to due diligence, negotiation of definitive agreements, and customary closing conditions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timel","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL58F7X5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","SPRC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.scisparc.com","stockEarnings":[{"period":"1week","weight":-0.1427},{"period":"1month","weight":-0.4611},{"period":"3month","weight":-0.7493},{"period":"6month","weight":-0.8576},{"period":"1year","weight":-0.9187},{"period":"ytd","weight":-0.4452}],"compareEarnings":[{"period":"1week","weight":-0.0086},{"period":"1month","weight":0.0093},{"period":"3month","weight":0.0176},{"period":"6month","weight":0.0906},{"period":"1year","weight":0.1535},{"period":"ytd","weight":0.0112}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.075328},{"month":2,"riseRate":0.2,"avgChangeRate":-0.088455},{"month":3,"riseRate":0,"avgChangeRate":-0.33348},{"month":4,"riseRate":0.25,"avgChangeRate":0.005877},{"month":5,"riseRate":0.5,"avgChangeRate":-0.039695},{"month":6,"riseRate":0,"avgChangeRate":-0.156179},{"month":7,"riseRate":0,"avgChangeRate":-0.243864},{"month":8,"riseRate":0,"avgChangeRate":-0.467442},{"month":9,"riseRate":0.25,"avgChangeRate":0.236982},{"month":10,"riseRate":0.75,"avgChangeRate":0.077569},{"month":11,"riseRate":0.5,"avgChangeRate":0.007927},{"month":12,"riseRate":0.25,"avgChangeRate":-0.090986}],"exchange":"NASDAQ","name":"SciSparc Ltd.","nameEN":"SciSparc Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SciSparc Ltd.(SPRC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SciSparc Ltd.(SPRC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SciSparc Ltd.,SPRC,SciSparc Ltd.股票,SciSparc Ltd.股票老虎,SciSparc Ltd.股票老虎国际,SciSparc Ltd.行情,SciSparc Ltd.股票行情,SciSparc Ltd.股价,SciSparc Ltd.股市,SciSparc Ltd.股票价格,SciSparc Ltd.股票交易,SciSparc Ltd.股票购买,SciSparc Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SciSparc Ltd.(SPRC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SciSparc Ltd.(SPRC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}